FDA Drug Recalls

Recalls / Class II

Class IID-1082-2020

Product

nICARdipine HCl (0.1 mg/mL) 1 mg/10mL, in 0.9% Sodium Chloride Injection USP, 10 ml in a 20mL syringe, Rx Only, PharMEDium Services LLC 12620 W. Airport Boulevard #130 Sugar Land, TX 77470. NDC 71019-206-01

Affected lot / code info
193540006D, Exp 3/22/2020

Why it was recalled

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

Recalling firm

Firm
PharMEDium Services, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
36 Stults Rd, N/A, Dayton, New Jersey 08810

Distribution

Quantity
80 units
Distribution pattern
Distributed Nationwide in the US

Timeline

Recall initiated
2020-03-16
FDA classified
2020-04-06
Posted by FDA
2020-04-15
Terminated
2025-02-14
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1082-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls